Ondine Biomedical Inc. OBIMF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.89% | 3.16% | 1.20% | -35.64% | -3.73% |
| Total Depreciation and Amortization | -0.86% | 4.18% | -1.18% | -9.29% | 3.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.89% | 39.87% | -1.20% | 114.68% | 3.72% |
| Change in Net Operating Assets | -0.89% | -35.64% | -1.21% | 28.64% | 3.72% |
| Cash from Operations | 0.89% | 1.00% | 1.20% | -34.98% | -3.73% |
| Capital Expenditure | 0.97% | -23.35% | 1.18% | -288.51% | -3.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.97% | -23.35% | 1.18% | -288.51% | -3.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 3.70% | 0.00% | 25.69% | 0.00% |
| Issuance of Common Stock | 0.00% | -54.83% | 0.00% | 250.20% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 48.27% | 0.00% | -6,086.36% | 0.00% |
| Cash from Financing | -0.89% | -55.03% | -1.20% | 239.39% | 3.73% |
| Foreign Exchange rate Adjustments | 1.04% | -205.49% | -1.09% | -75.36% | 3.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.89% | -206.61% | -1.21% | 215.21% | -3.73% |